Date of download: 9/17/2016 From: Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments: A Systematic Review and Network.

Slides:



Advertisements
Similar presentations
Consider this Combo: GLP-1 Receptor Agonists and Basal Insulin Matt Heinsen, PharmD PGY2 Pharmacotherapy Resident Butler University & Community Health.
Advertisements

Date of download: 5/27/2016 From: Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health.
Date of download: 5/28/2016 From: United Kingdom Prospective Diabetes Study 17: A 9-Year Update of a Randomized, Controlled Trial on the Effect of Improved.
Date of download: 5/28/2016 From: Optimal Timing of Coronary Invasive Strategy in Non–ST-Segment Elevation Acute Coronary Syndromes: A Systematic Review.
Date of download: 5/29/2016 From: Systematic Review: Comparative Effectiveness and Safety of Premixed Insulin Analogues in Type 2 Diabetes Ann Intern Med.
Date of download: 5/30/2016 From: Effects of Initiating Moderate Alcohol Intake on Cardiometabolic Risk in Adults With Type 2 Diabetes: A 2-Year Randomized,
Date of download: 5/31/2016 From: Urinary Biomarkers for Diagnosis of Bladder Cancer: A Systematic Review and Meta-analysis Ann Intern Med. 2015;163(12):
Date of download: 5/31/2016 From: Metabolic Risk Factors Worsen Continuously across the Spectrum of Nondiabetic Glucose Tolerance: The Framingham Offspring.
Date of download: 6/2/2016 From: Antibiotic Self-stewardship: Trainee-Led Structured Antibiotic Time-outs to Improve Antimicrobial Use Ann Intern Med.
Date of download: 6/2/2016 From: Screening for Vitamin D Deficiency: A Systematic Review for the U.S. Preventive Services Task Force Ann Intern Med. 2015;162(2):
Date of download: 6/2/2016 From: Are Metabolically Healthy Overweight and Obesity Benign Conditions?: A Systematic Review and Meta- analysis Ann Intern.
Date of download: 6/2/2016 From: Safety and Effectiveness of Recombinant Human Bone Morphogenetic Protein-2 for Spinal Fusion: A Meta-analysis of Individual-Participant.
Date of download: 6/3/2016 From: Surgery Versus Nonsurgical Treatment of Lumbar Spinal Stenosis: A Randomized Trial Ann Intern Med. 2015;162(7):
Date of download: 6/3/2016 From: The Effect of Erythropoietin-Stimulating Agents on Health-Related Quality of Life in Anemia of Chronic Kidney Disease:
Date of download: 6/3/2016 From: Radial Versus Femoral Access in Invasively Managed Patients With Acute Coronary Syndrome: A Systematic Review and Meta-analysis.
Date of download: 6/6/2016 From: Comparative Effectiveness of Pain Management Interventions for Hip Fracture: A Systematic Review Ann Intern Med. 2011;155(4):
Date of download: 6/18/2016 From: Treatment of Anemia in Patients With Heart Disease: A Systematic Review Ann Intern Med. 2013;159(11): doi: /
Date of download: 6/21/2016 From: Psychological and Behavioral Interventions for Managing Insomnia Disorder: An Evidence Report for a Clinical Practice.
Date of download: 6/21/2016 From: Pharmacist-led Chronic Disease Management: A Systematic Review of Effectiveness and Harms Compared With Usual Care Ann.
Date of download: 6/22/2016 From: The Efficacy of Influenza Vaccine in Elderly Persons: A Meta-Analysis and Review of the Literature Ann Intern Med. 1995;123(7):
Date of download: 6/22/2016 From: Systematic Review: Anti–Epidermal Growth Factor Receptor Treatment Effect Modification by KRAS Mutations in Advanced.
Date of download: 6/22/2016 From: Prolonged Versus Standard-Duration Venous Thromboprophylaxis in Major Orthopedic Surgery: A Systematic Review Ann Intern.
Date of download: 6/23/2016 From: Screening for, Monitoring, and Treatment of Chronic Kidney Disease Stages 1 to 3: A Systematic Review for the U.S. Preventive.
Date of download: 6/23/2016 From: Meta-Analysis: Acupuncture for Low Back Pain Ann Intern Med. 2005;142(8): doi: /
Date of download: 6/24/2016 From: Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus: A Systematic.
Date of download: 6/24/2016 From: Effectiveness of Manual Physical Therapy and Exercise in Osteoarthritis of the Knee: A Randomized, Controlled Trial Ann.
Date of download: 6/24/2016 From: Systematic Review: Benefits and Harms of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications Ann Intern.
Date of download: 6/24/2016 From: Sodium–Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes: A Systematic Review and Meta-analysis Ann Intern Med.
Date of download: 6/25/2016 From: Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis Ann Intern Med. 2015;163(3):
Date of download: 6/26/2016 From: Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus: A Systematic.
Date of download: 6/28/2016 From: Meta-Analysis: Low-Dose Dopamine Increases Urine Output but Does Not Prevent Renal Dysfunction or Death Ann Intern Med.
Date of download: 6/28/2016 From: Drug Treatment of Hypertension in the Elderly: A Meta-Analysis Ann Intern Med. 1994;121(5): doi: /
Date of download: 6/29/2016 From: Long-Term Health Outcomes in Women With Silicone Gel Breast Implants: A Systematic Review Ann Intern Med. 2016;164(3):
Date of download: 7/5/2016 From: Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic.
Date of download: 7/5/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of High vs Low Glycemic Index of Dietary Carbohydrate.
Date of download: 7/5/2016 From: Inhaled Insulin Improves Glycemic Control When Substituted for or Added to Oral Combination Therapy in Type 2 Diabetes:
Date of download: 7/7/2016 From: The Association between Common Vitamin D Receptor Gene Variations and Osteoporosis: A Participant-Level Meta-Analysis.
Date of download: 7/8/2016 From: Economic Outcomes With Anatomical Versus Functional Diagnostic Testing for Coronary Artery Disease Ann Intern Med. Published.
Date of download: 7/8/2016 From: Did Medicare Part D Affect National Trends in Health Outcomes or Hospitalizations?: A Time-Series Analysis Ann Intern.
Date of download: 7/8/2016 From: Longer- Versus Shorter-Duration Dual-Antiplatelet Therapy After Drug-Eluting Stent Placement: A Systematic Review and.
Date of download: 7/11/2016 From: Safety of Herpes Zoster Vaccine in the Shingles Prevention Study: A Randomized Trial Ann Intern Med. 2010;152(9):
Date of download: 7/13/2016 From: Screening for and Treatment of Suicide Risk Relevant to Primary Care: A Systematic Review for the U.S. Preventive Services.
Date of download: 9/17/2016 From: Behavioral Therapy to Enable Women with Urge Incontinence to Discontinue Drug Treatment: A Randomized Trial Ann Intern.
Date of download: 9/17/2016 From: Topical Treatment of Pressure Ulcers with Nerve Growth Factor: A Randomized Clinical Trial Ann Intern Med. 2003;139(8):
Date of download: 9/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Insulin Therapy for Type 2 Diabetes Mellitus JAMA.
Date of download: 9/17/2016 From: Effectiveness of Primary Care–Relevant Treatments for Obesity in Adults: A Systematic Evidence Review for the U.S. Preventive.
Date of download: 9/18/2016 From: Behavioral Programs for Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-analysis Ann Intern Med. 2015;163(11):
Date of download: 9/19/2016 From: Narrative Review: Lack of Evidence for Recommended Low-Density Lipoprotein Treatment Targets: A Solvable Problem Ann.
Date of download: 11/12/2016 From: Association Between Efavirenz as Initial Therapy for HIV-1 Infection and Increased Risk for Suicidal Ideation or Attempted.
From: Two Ways of Knowing: Big Data and Evidence-Based Medicine
From: Biological Agents for Moderately to Severely Active Ulcerative ColitisA Systematic Review and Network Meta-analysis Ann Intern Med. 2014;160(10):
From: Benefits and Harms of Statin Therapy for Persons With Chronic Kidney DiseaseA Systematic Review and Meta-analysis Ann Intern Med. 2012;157(4):
From: Conceptual and Technical Challenges in Network Meta-analysis
Taieb V, et al. Value Health Nov;18(7):A598.
From: Effects of Low-Carbohydrate and Low-Fat DietsA Randomized Trial
From: Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve ReplacementA Systematic Review and Meta-analysis Ann Intern Med. 2016;165(5):
From: Diagnostic and Predictive Accuracy of Blood Pressure Screening Methods With Consideration of Rescreening Intervals: A Systematic Review for the U.S.
Ann Intern Med. 2014;160(11): doi: /M Figure Legend:
From: Pharmacologic Therapy for Type 2 Diabetes Mellitus
From: Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve ReplacementA Systematic Review and Meta-analysis Ann Intern Med. 2016;165(5):
Copyright © 2011 American Medical Association. All rights reserved.
From: Wells Rule and d-Dimer Testing to Rule Out Pulmonary EmbolismA Systematic Review and Individual-Patient Data Meta-analysis Ann Intern Med. 2016;165(4):
Ann Intern Med. 1999;130(6): doi: / Figure Legend:
Ann Intern Med. 1995;123(2): doi: / Figure Legend:
From: Systematic Review: Strategies for Using Exercise Therapy To Improve Outcomes in Chronic Low Back Pain Ann Intern Med. 2005;142(9): doi: /
Copyright © 2002 American Medical Association. All rights reserved.
From: Diagnostic Accuracy of an “Amended” Insulin–Glucose Ratio for the Biochemical Diagnosis of Insulinomas Ann Intern Med. 2012;157(11): doi: /
From: United Kingdom Prospective Diabetes Study 17: A 9-Year Update of a Randomized, Controlled Trial on the Effect of Improved Metabolic Control on Complications.
From: Self-Measured Blood Pressure Monitoring in the Management of HypertensionA Systematic Review and Meta-analysis Ann Intern Med. 2013;159(3):
From: Clinic-Based Treatment of Opioid-Dependent HIV-Infected Patients Versus Referral to an Opioid Treatment ProgramA Randomized Trial Ann Intern Med.
Presentation transcript:

Date of download: 9/17/2016 From: Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments: A Systematic Review and Network Meta-analysis Ann Intern Med. 2016;164(2): doi: /M Summary of evidence search and selection. For PubMed, the search was “Exenatide” OR “Taspoglutide” OR “Albiglutide” OR “Dulaglutide” OR “Semaglutide”; limits: Humans and Randomized Controlled Trial. The search strategy was specifically translated for other databases. RCT = randomized, controlled trial. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

Date of download: 9/17/2016 From: Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments: A Systematic Review and Network Meta-analysis Ann Intern Med. 2016;164(2): doi: /M Network maps for cardiometabolic and safety outcomes. Nodes represent the treatments being compared; their size is proportional to the number of participants. Edges represent the available direct comparisons between pairs of treatments, and their width is proportional to the number of trials comparing every pair. ALB = albiglutide; BASAL = basal insulin; dGLP1 = daily glucagon-like peptide-1 receptor agonists; DUL 0.75 = dulaglutide, 0.75 mg; DUL 1.5 = dulaglutide, 1.5 mg; EOW = exenatide once-weekly; GLIM = glimepiride; HbA 1c = hemoglobin A 1c ; HDL = high-density lipoprotein; LDL = low-density lipoprotein; MET = metformin; PIO = pioglitazone; PLA = placebo; RAPID = rapid insulin; SITA = sitagliptin; TAS 10 = taspoglutide, 10 mg; TAS 20 = taspoglutide, 20 mg. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

Date of download: 9/17/2016 From: Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments: A Systematic Review and Network Meta-analysis Ann Intern Med. 2016;164(2): doi: /M Pairwise random-effects meta-analysis for the primary outcome (HbA 1c ). Mean differences are reported for comparisons with at least 1 once-weekly GLP-1RA group. GLP-1RA = glucagon-like peptide-1 receptor agonist; HbA 1c = hemoglobin A 1c. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

Date of download: 9/17/2016 From: Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments: A Systematic Review and Network Meta-analysis Ann Intern Med. 2016;164(2): doi: /M Differences versus placebo (dashed line) for cardiometabolic outcomes. ALB = albiglutide; BASAL = basal insulin; dGLP1 = daily glucagon-like peptide-1 receptor agonists; DUL 0.75 = dulaglutide, 0.75 mg; DUL 1.5 = dulaglutide, 1.5 mg; EOW = exenatide once-weekly; FPG = fasting plasma glucose; GLIM = glimepiride; HbA 1c = hemoglobin A 1c ; HDL = high-density lipoprotein; LDL = low-density lipoprotein; MET = metformin; PIO = pioglitazone; PLA = placebo; RAPID = rapid insulin; SITA = sitagliptin; TAS 10 = taspoglutide, 10 mg; TAS 20 = taspoglutide, 20 mg. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

Date of download: 9/17/2016 From: Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments: A Systematic Review and Network Meta-analysis Ann Intern Med. 2016;164(2): doi: /M Comparison of once-weekly glucagon-like peptide-1 receptor agonists for cardiometabolic outcomes. Data are reported as mean differences (95% CIs) and indicate differences versus the reference drug (for example, compared with dulaglutide, 1.5 mg, albiglutide increases HbA 1c by 0.40% [CI, 0.17% to 0.63%]). ALB = albiglutide; DUL 0.75 = dulaglutide, 0.75 mg; DUL 1.5 = dulaglutide, 1.5 mg; EOW = exenatide once-weekly; HbA 1c = hemoglobin A 1c ; HDL = high-density lipoprotein; LDL = low-density lipoprotein; TAS 10 = taspoglutide, 10 mg; TAS 20 = taspoglutide, 20 mg. * To convert values to mg/dL, divide by † To convert values to mg/dL, divide by ‡ To convert values to mg/dL, divide by Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

Date of download: 9/17/2016 From: Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments: A Systematic Review and Network Meta-analysis Ann Intern Med. 2016;164(2): doi: /M Rank probabilities for the primary outcome (hemoglobin A 1c ). GLP-1RA = glucagon-like peptide-1 receptor agonist. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

Date of download: 9/17/2016 From: Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments: A Systematic Review and Network Meta-analysis Ann Intern Med. 2016;164(2): doi: /M Differences versus placebo (dashed line) for safety outcomes. ALB = albiglutide; BASAL = basal insulin; dGLP1 = daily glucagon-like peptide-1 receptor agonists; DUL 0.75 = dulaglutide, 0.75 mg; DUL 1.5 = dulaglutide, 1.5 mg; EOW = exenatide once-weekly; GLIM = glimepiride; MET = metformin; PIO = pioglitazone; PLA = placebo; RAPID = rapid insulin; SITA = sitagliptin; TAS 10 = taspoglutide, 10 mg; TAS 20 = taspoglutide, 20 mg. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

Date of download: 9/17/2016 From: Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments: A Systematic Review and Network Meta-analysis Ann Intern Med. 2016;164(2): doi: /M Comparison of once-weekly glucagon-like peptide-1 receptor agonists for safety outcomes. Data are reported as odds ratios (95% CIs) and indicate differences versus the reference drug (for example, compared with dulaglutide, 1.5 mg, treatment with dulaglutide, 0.75 mg, is associated with an odds ratio for nausea of 0.56 [CI, 0.45 to 0.69]). ALB = albiglutide; DUL 0.75 = dulaglutide, 0.75 mg; DUL 1.5 = dulaglutide, 1.5 mg; EOW = exenatide once-weekly; HbA 1c = hemoglobin A 1c ; HDL = high-density lipoprotein; LDL = low- density lipoprotein; TAS 10 = taspoglutide, 10 mg; TAS 20 = taspoglutide, 20 mg. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.